Episode
PeDRA at SID - A Patient Advocacy Perspective
- Podcast
- PeDRA Pearls
- Published
- May 20, 2026
- Duration seconds
- 667
- Processing state
not_requested- Canonical source
- https://pedra-podcasts.captivate.fm
Actions
POST https://stenobird.com/v1/public/podcasts/pedra-pearls-1565679/episodes/pedra-at-sid-a-patient-advocacy-perspective/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/pedra-pearls-1565679/pedra-at-sid-a-patient-advocacy-perspective.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Meredith Weiss joins the podcast to discuss a study that was presented in the inaugural Gorlin Syndrome Alliance Round Table session at the Society for Investigative Dermatology (SID) meeting. Meredith is the Executive Director for the Gorlin Syndrome Alliance. Novel PTCH1 Variants in Gorlin Syndrome Identified through Genomic Analysis of 118 Patients. The authors of this study are: Ryan Kern*1, Amy Xiong1, Qianqian Wang2, Philip Beachy2, Jean Tang1 1Department of Dermatology, Stanford University School of Medicine, Stanford, California, United States; 2Department of Developmental Biology, Stanford University School of Medicine, Stanford, California, United States Please click here for more information about the Gorlin Syndrome Alliance.